Patrizia Giannatempo, Medical Oncology Consultant at the National Cancer Institute (INT) in Milan, shared a post on X:
“Insightful session by Roberto Iacovelli at AIOM25 on adjuvant approaches in RCC. The CARE1 experience highlights how global collaboration can refine patient selection and guide real-world therapeutic choices”
More posts featuring Patrizia Giannatempo on OncoDaily.
